Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Simó

Showing results (221-230 of 328) with videos related to

Pageof 33
Sort By:
Journal of Clinical Medicine|September 11, 2019
Assessment of Inner Retinal Layers and Choroidal Thickness in Type 1 Diabetes Mellitus: A Cross-Sectional StudyMarc Carbonell, Núria Alonso, Esmeralda Castelblanco, et al.
Journal of Clinical Medicine|August 28, 2020
Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in SpainAngel Michael Ortiz Zuñiga, Rafael Simó, Octavio Rodriguez-Gómez, et al.
International Journal of Molecular Sciences|July 27, 2019
SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental DiabetesCristina Hernández, Patricia Bogdanov, Carmen Gómez-Guerrero, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Contribution of Dynamic and Genetic Tests for Short Stature Diagnosing: A Case ReportBetina Biagetti, Irene Valenzuela, Ariadna Campos-Martorell, et al.
Lancet (London, England)|June 12, 2012
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trialBaptist Gallwitz, Juan Guzman, Francesco Dotta, et al.
Journal of Clinical Medicine|May 31, 2020
A Translational In Vivo and In Vitro Metabolomic Study Reveals Altered Metabolic Pathways in Red Blood Cells of Type 2 DiabetesMartina Palomino-Schätzlein, Rubén Lamas-Domingo, Andreea Ciudin, et al.
Journal of Clinical Medicine|October 14, 2023
Efficacy of Insulin Titration Driven by SMS in Improving Glycemic Control in People with Type 2 DiabetesÁngel Ortiz-Zúñiga, Olga Simó-Servat, Judit Amigó, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2017
Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 DiabetesCarolina López-Cano, Albert Lecube, Marta García-Ramírez, et al.
Diabetes|September 18, 2023
Blocking Hemopexin With Specific Antibodies: A New Strategy for Treating Diabetic RetinopathyPatricia Bogdanov, Anna Duarri, David Sabater, et al.
Frontiers in Medicine|September 2, 2022
Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetesJoan Barrot, Jordi Real, Bogdan Vlacho, et al.
Pageof 33

Showing results (221-230 of 328) with videos related to

Sort By:
Pageof 33
Journal of Clinical Medicine|September 11, 2019
Assessment of Inner Retinal Layers and Choroidal Thickness in Type 1 Diabetes Mellitus: A Cross-Sectional StudyMarc Carbonell, Núria Alonso, Esmeralda Castelblanco, et al.
Journal of Clinical Medicine|August 28, 2020
Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in SpainAngel Michael Ortiz Zuñiga, Rafael Simó, Octavio Rodriguez-Gómez, et al.
International Journal of Molecular Sciences|July 27, 2019
SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental DiabetesCristina Hernández, Patricia Bogdanov, Carmen Gómez-Guerrero, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
Contribution of Dynamic and Genetic Tests for Short Stature Diagnosing: A Case ReportBetina Biagetti, Irene Valenzuela, Ariadna Campos-Martorell, et al.
Lancet (London, England)|June 12, 2012
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trialBaptist Gallwitz, Juan Guzman, Francesco Dotta, et al.
Journal of Clinical Medicine|May 31, 2020
A Translational In Vivo and In Vitro Metabolomic Study Reveals Altered Metabolic Pathways in Red Blood Cells of Type 2 DiabetesMartina Palomino-Schätzlein, Rubén Lamas-Domingo, Andreea Ciudin, et al.
Journal of Clinical Medicine|October 14, 2023
Efficacy of Insulin Titration Driven by SMS in Improving Glycemic Control in People with Type 2 DiabetesÁngel Ortiz-Zúñiga, Olga Simó-Servat, Judit Amigó, et al.
The Journal of Clinical Endocrinology and Metabolism|September 26, 2017
Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 DiabetesCarolina López-Cano, Albert Lecube, Marta García-Ramírez, et al.
Diabetes|September 18, 2023
Blocking Hemopexin With Specific Antibodies: A New Strategy for Treating Diabetic RetinopathyPatricia Bogdanov, Anna Duarri, David Sabater, et al.
Frontiers in Medicine|September 2, 2022
Diabetic retinopathy as a predictor of cardiovascular morbidity and mortality in subjects with type 2 diabetesJoan Barrot, Jordi Real, Bogdan Vlacho, et al.
Pageof 33